Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage

NCT01563445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Bleeding Disorder
Intracerebral Haemorrhage

Interventions

DRUG: activated recombinant human factor VII
DRUG: placebo

Sponsor

Novo Nordisk A/S